Abstract P1-15-14: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of triple negative breast cancer by Chan, N, Riedlinger, GM, Lu, S-e, Pham, KT, Kirstein, LJ, Eladoumikdachi, FG, George, MA, Potdevin, LB, Kowzun, MJ, Desai, SA, Tang, DM, Omene, CO, Wong, ST, Rodriguez-Rust, L, Kumar, S, Kearney, TJ, Liu, C, Ganesan, S, Toppmeyer, DL, Hirshfield, KM

Get full text